Univariate analysis suggested that age, location of lesions, T-stage, histology, ER, PR, HER2, tumor grade and LVI were risk factors for pN2–3 disease in patients with any positive ALNs (Table 3). The gene discussed is ERBB2; the disease is neoplasm.